Recon: European experts unconvinced by Eisai, Biogen Alzheimer’s drug; FDA seeking new methotrexate suppliers amid cancer drug shortages
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy